Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03681353 · ClinicalTrials.gov registry record · NA
Impact of Reduced Cannabis Use on Functional Outcomes
A NA study of Cannabis Use and Cannabis, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT03681353: Completed NA study of Cannabis Use and Cannabis, sponsored by Duke University.
NCT03681353 is a NA study of Cannabis Use and Cannabis that has completed, run by Duke University. The registered enrollment target is 25 participants, below the 279-participant average among 44 other Cannabis Use trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03681353, a NA study of Cannabis Use and Cannabis, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Nearly 20 million Americans report use of cannabis in the past month, and heavy cannabis use has increased by nearly 60% in the U.S. since 2007. Heavy cannabis use is associated with lower educational attainment, reduced physical activity, and increased rates of addiction, unemployment, and neuropsychological deficits. Studies by the lab and others suggest that cannabis use is also associated with increased mental health symptoms and suicidal and nonsuicidal self-injury. In addition, cannabis is the illicit drug most strongly associated with drugged driving and traffic accidents, including fatal accidents. There is evidence that sustained abstinence from cannabis can lead to improvements in the functional outcomes of former users. However, he degree to which reductions in cannabis use might be associated with positive changes in functional outcomes is currently unknown. The overall objective of the present research is to use ecological momentary assessment (EMA), a real-time, naturalistic data collection method, to study the impact of reduced cannabis use on functional outcomes in heavy cannabis users. Contingency management (CM) will be used to promote reductions in frequency and quantity of cannabis use. CM is an intensive behavioral therapy that is highly effective at producing short-term reductions in illicit drug use. The investigators novel approach includes mobile technology to make CM more portable and feasible. The present research will use this technology in conjunction with state-of-the-art EMA methods to study the impact of reduced cannabis use on key functional outcomes. The investigators central hypothesis is that reductions in frequency and quantity of cannabis use will lead to positive changes in cannabis users' mental health, physical activity, working memory, health-related quality of life, and driving behavior.
Primary Outcome
Adherence is defined as completing the baseline assessment
Conditions Studied
Interventions
- BEHAVIORAL Mobile Contingency Management, active
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-04-04 |
| Est. Completion | 2020-09-23 |
| Phase | NA |
What the finished NCT03681353 record still lists
NCT03681353 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 279-participant average among 44 other Cannabis Use trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Cannabis Use appearing as the primary indexed condition, and to 1 intervention - of which Mobile Contingency Management, active is the first listed.
NCT03681353 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03681353 about?
NCT03681353 is a clinical study titled "Impact of Reduced Cannabis Use on Functional Outcomes". Nearly 20 million Americans report use of cannabis in the past month, and heavy cannabis use has increased by nearly 60% in the U.S. since 2007. Heavy cannabis use is associated with lower educational attainment, reduced physical activity, and increased rates of addiction, unemployment, and neuropsy...
What is the current status of trial NCT03681353?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-04-04. Estimated completion is 2020-09-23.
What conditions does trial NCT03681353 study?
This clinical trial studies the following conditions: Cannabis Use, Cannabis.
What interventions are being tested in trial NCT03681353?
The interventions under investigation include: Mobile Contingency Management, active (BEHAVIORAL).
Who is sponsoring clinical trial NCT03681353?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03681353 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03681353's enrollment target sits among peer trials
25 40th of 44 higher than 5 of 44 other Cannabis Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility/Acceptability of a Brief Motivational Intervention for Frequent/High-Intensity Cannabis Use
RECRUITING · NA
-
Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
RECRUITING · NA
-
Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
RECRUITING · NA
-
Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
RECRUITING · NA
-
Cannabis THC Potency, Metabolism, and Cognitive Impairment in Young Adults
RECRUITING · NA
-
Stress and Resilience
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI